Yikang Biotech (Suzhou) Co., Ltd.
Yikang Biotech (Suzhou) Co., Ltd.
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Preliminary Immunogenicity of Recombinant RSV Vaccine （CHO Cell） in Adults Aged 18 Years and Older | Respiratory Syncytial Virus (RSV) | Not yet recruiting | Phase 1 | 2026-09-08 | NCT07807449 |